BEAM
Price
$17.83
Change
-$1.70 (-8.70%)
Updated
Apr 1, 03:57 PM (EDT)
Capitalization
2.22B
42 days until earnings call
NTLA
Price
$6.66
Change
-$0.45 (-6.33%)
Updated
Apr 1, 03:38 PM (EDT)
Capitalization
835.39M
30 days until earnings call
Ad is loading...

BEAM vs NTLA

Header iconBEAM vs NTLA Comparison
Open Charts BEAM vs NTLABanner chart's image
Beam Therapeutics
Price$17.83
Change-$1.70 (-8.70%)
Volume$2.33K
Capitalization2.22B
Intellia Therapeutics
Price$6.66
Change-$0.45 (-6.33%)
Volume$5.21K
Capitalization835.39M
BEAM vs NTLA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. NTLA commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (BEAM: $19.53 vs. NTLA: $7.11)
Brand notoriety: BEAM and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 308% vs. NTLA: 202%
Market capitalization -- BEAM: $2.22B vs. NTLA: $835.39M
BEAM [@Biotechnology] is valued at $2.22B. NTLA’s [@Biotechnology] market capitalization is $835.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • NTLA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BEAM and NTLA are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -18.66% price change this week, while NTLA (@Biotechnology) price change was -23.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.81%. For the same industry, the average monthly price growth was -13.05%, and the average quarterly price growth was -11.98%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

NTLA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.22B) has a higher market cap than NTLA($835M). BEAM YTD gains are higher at: -21.250 vs. NTLA (-39.022). BEAM has higher annual earnings (EBITDA): -383.98M vs. NTLA (-523.98M). BEAM has more cash in the bank: 851M vs. NTLA (602M). BEAM has less debt than NTLA: BEAM (161M) vs NTLA (210M). BEAM has higher revenues than NTLA: BEAM (63.5M) vs NTLA (57.9M).
BEAMNTLABEAM / NTLA
Capitalization2.22B835M266%
EBITDA-383.98M-523.98M73%
Gain YTD-21.250-39.02254%
P/E RatioN/AN/A-
Revenue63.5M57.9M110%
Total Cash851M602M141%
Total Debt161M210M77%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMNTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 9 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBAKX28.66N/A
N/A
Fidelity Balanced K
APGRX18.18N/A
N/A
Yorktown Growth Institutional
MISGX11.72N/A
N/A
Meridian Small Cap Growth Investor
GTFPX28.76N/A
N/A
Goldman Sachs International Eq ESG P
THGCX23.30-0.24
-1.02%
Thornburg International Equity C